Xylem (NYSE:XYL) Releases Earnings Results, Beats Estimates By $0.12 EPS

Xylem (NYSE:XYL) announced its earnings results on Tuesday. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12, Zacks reports. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The company had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. During the same period in the previous year, the firm earned $1.26 earnings per share. Xylem’s revenue for the quarter was up 1.5% compared to the same quarter last year. Xylem updated its FY 2026 guidance to 5.550-5.700 EPS.

Xylem Price Performance

Shares of NYSE:XYL opened at $120.20 on Tuesday. The firm has a market cap of $28.57 billion, a price-to-earnings ratio of 29.90, a P/E/G ratio of 1.70 and a beta of 1.03. Xylem has a 1 year low of $105.29 and a 1 year high of $154.27. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. The business has a fifty day simple moving average of $114.27 and a 200 day simple moving average of $122.55.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is currently 42.79%.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. JPMorgan Chase & Co. cut their price objective on Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Barclays dropped their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 29th. CLSA upgraded shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. Stifel Nicolaus decreased their price objective on shares of Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a research note on Monday, July 20th. Finally, Citigroup lowered their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $153.15.

Insider Transactions at Xylem

In other news, Director Jerome A. Peribere bought 1,210 shares of the company’s stock in a transaction on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the transaction, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.32% of the company’s stock.

Hedge Funds Weigh In On Xylem

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC grew its position in Xylem by 14.4% in the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock worth $3,645,000 after acquiring an additional 3,900 shares in the last quarter. NewEdge Advisors LLC raised its holdings in shares of Xylem by 3.3% during the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after purchasing an additional 132 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Xylem by 56.1% in the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in Xylem by 97.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock worth $1,442,000 after purchasing an additional 5,509 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock worth $154,000 after purchasing an additional 635 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.